DOP037. Initial Adequate Trough Concentrations during Induction Therapy Correlate with Sustained TNF Suppression and Predict Remission with Adalimumab in Anti-TNF Naive Crohn's Disease Patients | Zendy

AI Assistant Blog Pricing

DOP037. Initial Adequate Trough Concentrations during Induction Therapy Correlate with Sustained TNF Suppression and Predict Remission with Adalimumab in Anti-TNF Naive Crohn's Disease Patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.